3b6e
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3b6e]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B6E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3B6E FirstGlance]. <br> | <table><tr><td colspan='2'>[[3b6e]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3B6E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3B6E FirstGlance]. <br> | ||
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IFIH1, MDA5, RH116 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IFIH1, MDA5, RH116 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3b6e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3b6e OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3b6e RCSB], [http://www.ebi.ac.uk/pdbsum/3b6e PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3b6e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3b6e OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3b6e RCSB], [http://www.ebi.ac.uk/pdbsum/3b6e PDBsum]</span></td></tr> |
- | <table> | + | </table> |
== Disease == | == Disease == | ||
[[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Genetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:[http://omim.org/entry/610155 610155]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:16699517</ref> Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).<ref>PMID:19565506</ref> <ref>PMID:20015976</ref> | [[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Genetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:[http://omim.org/entry/610155 610155]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:16699517</ref> Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).<ref>PMID:19565506</ref> <ref>PMID:20015976</ref> | ||
Line 26: | Line 26: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: Arrowsmith, C H | + | [[Category: Arrowsmith, C H]] |
- | [[Category: Berg, S Van Den | + | [[Category: Berg, S Van Den]] |
- | [[Category: Berglund, H | + | [[Category: Berglund, H]] |
- | [[Category: Busam, R D | + | [[Category: Busam, R D]] |
- | [[Category: Collins, R | + | [[Category: Collins, R]] |
- | [[Category: Dahlgren, L G | + | [[Category: Dahlgren, L G]] |
- | [[Category: Edwards, A M | + | [[Category: Edwards, A M]] |
- | [[Category: Flodin, S | + | [[Category: Flodin, S]] |
- | [[Category: Flores, A | + | [[Category: Flores, A]] |
- | [[Category: Graslund, S | + | [[Category: Graslund, S]] |
- | [[Category: Hammarstrom, M | + | [[Category: Hammarstrom, M]] |
- | [[Category: Holmberg-Schiavone, L | + | [[Category: Holmberg-Schiavone, L]] |
- | [[Category: Johansson, I | + | [[Category: Johansson, I]] |
- | [[Category: Kallas, A | + | [[Category: Kallas, A]] |
- | [[Category: Karlberg, T | + | [[Category: Karlberg, T]] |
- | [[Category: Kotenyova, T | + | [[Category: Kotenyova, T]] |
- | [[Category: Lehtio, L | + | [[Category: Lehtio, L]] |
- | [[Category: Moche, M | + | [[Category: Moche, M]] |
- | [[Category: Nilsson, M E | + | [[Category: Nilsson, M E]] |
- | [[Category: Nordlund, P | + | [[Category: Nordlund, P]] |
- | [[Category: Nyman, T | + | [[Category: Nyman, T]] |
- | [[Category: Persson, C | + | [[Category: Persson, C]] |
- | [[Category: | + | [[Category: Structural genomic]] |
- | [[Category: Sagemark, J | + | [[Category: Sagemark, J]] |
- | [[Category: Svensson, L | + | [[Category: Svensson, L]] |
- | [[Category: Thorsell, A G | + | [[Category: Thorsell, A G]] |
- | [[Category: Tresaugues, L | + | [[Category: Tresaugues, L]] |
- | [[Category: Weigelt, J | + | [[Category: Weigelt, J]] |
- | [[Category: Welin, M | + | [[Category: Welin, M]] |
[[Category: Antiviral defense]] | [[Category: Antiviral defense]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
Line 69: | Line 69: | ||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Sgc]] | [[Category: Sgc]] | ||
- | [[Category: Structural genomic]] | ||
- | [[Category: Structural genomics consortium]] |
Revision as of 11:32, 20 January 2015
Crystal structure of human DECH-box RNA Helicase MDA5 (Melanoma differentiation-associated protein 5), DECH-domain
|
Categories: Homo sapiens | Arrowsmith, C H | Berg, S Van Den | Berglund, H | Busam, R D | Collins, R | Dahlgren, L G | Edwards, A M | Flodin, S | Flores, A | Graslund, S | Hammarstrom, M | Holmberg-Schiavone, L | Johansson, I | Kallas, A | Karlberg, T | Kotenyova, T | Lehtio, L | Moche, M | Nilsson, M E | Nordlund, P | Nyman, T | Persson, C | Structural genomic | Sagemark, J | Svensson, L | Thorsell, A G | Tresaugues, L | Weigelt, J | Welin, M | Antiviral defense | Atp-binding | Dech | Dexd/h rna-binding helicase | Diabetes mellitus | Host-virus interaction | Hydrolase | Ifih1 | Immune response | Innate immunity | Nucleotide-binding | Nucleus | Phosphorylation | Sgc